Search

Your search keyword '"Castagnoli, R."' showing total 201 results

Search Constraints

Start Over You searched for: Author "Castagnoli, R." Remove constraint Author: "Castagnoli, R."
201 results on '"Castagnoli, R."'

Search Results

1. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

3. Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19

4. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19

6. Inherited defects in the complement system

7. Urticaria in childhood

8. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

9. Immunological basis of virus-host interaction in COVID-19

10. Primary atopic disorders and chronic skin disease

11. Autoantibodies neutralizing type I IFNs are present in similar to 4\% of uninfected individuals over 70 years old and account for similar to 20\% of COVID-19 deaths

12. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

13. Evolution of Industry 4.0 and International Business:A Systematic Literature Review and a Research Agenda

14. Neutralizing type-I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID-19

17. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

18. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

19. Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic

20. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

21. Allergen immunotherapy for IgE-mediated food allergy: There is a measure in everything to a proper proportion of therapy

25. X-Linked Hypohidrotic Ectodermal Dysplasia: New Features and a Novel EDA Gene Mutation

26. Omalizumab in children with severe allergic asthma: The Italian real- life experience

27. Acetylcholine receptor-specific suppressive T-cell factor from a retrovirally transformed T-cell line.

36. ATOPIC DERMATITIS: IS THERE A ROLE FOR PROBIOTICS?

38. Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individuals

39. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19

40. Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic

41. Activated phosphoinositide 3‐dinase delta syndrome (APDS): An update

42. Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19

43. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

44. Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C

45. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

46. An immune-based biomarker signature is associated with mortality in COVID-19 patients

47. Neutralizing type-I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID-19

48. Tailored therapies for primary immunodeficiencies

49. Allergy and covid-19

50. Monkeypox 2024 outbreak: Fifty essential questions and answers.

Catalog

Books, media, physical & digital resources